Biogen Inc
NASDAQ:BIIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
TDH Holdings Inc
NASDAQ:PETZ
|
CN |
|
E
|
Enel SpA
OTC:ESOCF
|
IT |
|
Komori Corp
TSE:6349
|
JP |
|
H
|
Hang Feng Technology Innovation Co Ltd
NASDAQ:FOFO
|
HK |
|
FB Financial Corp
NYSE:FBK
|
US |
|
JEOL Ltd
TSE:6951
|
JP |
|
S
|
St Joe Co
XMUN:JOE
|
US |
|
Saratoga Investment Corp
NYSE:SAR
|
US |
|
AGNC Investment Corp
NASDAQ:AGNC
|
US |
Wall St Price Targets
BIIB Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for BIIB is 223.9 USD with a low forecast of 151.5 USD and a high forecast of 315 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIIB's stock price target?
Price Target
223.9
USD
According to Wall Street analysts, the average 1-year price target for BIIB is 223.9 USD with a low forecast of 151.5 USD and a high forecast of 315 USD.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 13%.
